Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C, Nilsson, S, Heinrich, D, Helle, S.I, O'Sullivan, J.M, Fosså, S.D, Chodacki, A, Wiechno, P, Logue, J, Seke, M, Widmark, A, Johannessen, D.C, Hoskin, P, Bottomley, D, James, N.D, Solberg, A, Syndikus, I, Kliment, J, Wedel, S, Boehmer, S, Dall'Oglio, M, Franzén, L, Coleman, R, Vogelzang, N.J, O'Bryan-Tear, C.G, Staudacher, K, Garcia-Vargas, J, Shan, M, Bruland, Ø.S, Sartor, O
Published in The New England journal of medicine (18.07.2013)
Published in The New England journal of medicine (18.07.2013)
Get full text
Journal Article
OC-0400: Dosimetric consequences of organ deformations in IMRT of locally advanced prostate cancer
Hysing, L, Thörnqvist, S, Zolnay, A, Ekanger, C, Söhn, M, Heijmen, B, Muren, L.P, Hoogeman, M, Sikora, M, Helle, S.I
Published in Radiotherapy and oncology (01.04.2015)
Published in Radiotherapy and oncology (01.04.2015)
Get full text
Journal Article
Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)
Thomsen, L.C.V., Honoré, A., Almås, B., Reisæter, L.A.R., Førde, K., Kristoffersen, E.K., Kaada, S.H., Melve, G.K., Helle, S.I., Kvalheim, G., Azeem, W., Olsen, J.R., Halvorsen, O.J., Akslen, L.A., Bahn, D., Pantel, K., Riethdorf, S., Ragde, H., Gjertsen, B.T., Øyan, A.M., Kalland, K.H., Beisland, C.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Assessing the Risk for Bowel Complications after Conformal and Intensity Modulated Pelvic Irradiation using Equivalent Uniform Doses
Muren, L.P, Hysing, L.B, Søndergaard, J, Karlsdottir, Á, Petersen, J.B, Helle, S.I, Høyer, M
Published in International journal of radiation oncology, biology, physics (2008)
Published in International journal of radiation oncology, biology, physics (2008)
Get full text
Journal Article
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
Sartor, O., Coleman, R.E., Nilsson, S., Heinrich, D., Helle, S.I., O’Sullivan, J.M., Vogelzang, N.J., Bruland, Ø., Kobina, S., Wilhelm, S., Xu, L., Shan, M., Kattan, M.W., Parker, C.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
101 Updated analysis of radium-223 dichloride (Ra-223) impact on pain, skeletal-related events (SRE), and survival from the phase 3 randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) and bone metastases
Heinrich, D, Helle, S.I, Chodacki, A, Wiechno, P, Garcia-Vargas, J, Staudacher, K, Parker, C
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Get full text
Journal Article
External-Beam Radiation Therapy (Ebrt) Use and Safety with Radium-223 Dichloride (Ra) in Patients (Pts) with Castration-Resistant Prostate Cancer (Crpc) and Symptomatic Bone Metastases (Mets) from the Alsympca Trial
O'Sullivan, J.M., Sartor, O., Parker, C., Hoskin, P., Widmark, A., Mellado, B., Helle, S.I., Aksnes, A., Garcia-Vargas, J.E., Nilsson, S.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
768PEXTERNAL-BEAM RADIATION THERAPY (EBRT) USE AND SAFETY WITH RADIUM-223 DICHLORIDE (RA) IN PATIENTS (PTS) WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) AND SYMPTOMATIC BONE METASTASES (METS) FROM THE ALSYMPCA TRIAL
O'Sullivan, J.M., Sartor, O., Parker, C., Hoskin, P., Widmark, A., Mellado, B., Helle, S.I., Aksnes, A., Garcia-Vargas, J.E., Nilsson, S.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)
Parker, C, Heinrich, D, Helle, S.I, O'Sullivan, J.M, Fossä, S, Chodacki, A, Demkow, T, Logue, J, Seke, M, Widmark, A, Johannessen, D.C, Nilsson, S, Hoskin, P, Bottomley, D, Solberg, A, James, N.D, Syndikus, I, Wedel, S.A, Kliment, J, Cross, A, O'Bryan-Tear, C.G, Garcia-Vargas, J, Sartor, O
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Get full text
Journal Article
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy
Helle, S.I., Mietlowski, W., Guastalla, J.P., Szakolczai, I., Bajetta, E., Sommer, H., Baltali, E., Pinter, T., Csepreghy, M., Ottestad, L., Boni, C., Bryce, C., Klijn, J.G.M., Lønning, P.E.
Published in European journal of cancer (1990) (01.03.2005)
Published in European journal of cancer (1990) (01.03.2005)
Get full text
Journal Article